Impact of Aerobic Training on Lung Function in Women With Fibromyalgia
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Fibromyalgia (FM)
- Sponsor
- Middle East University
- Enrollment
- 80
- Primary Endpoint
- Lung function
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
Exploring the effect of aerobic exercises on lung function, chest movement, and exercise capacity in women suffering from fibromyalgia.
Detailed Description
Eighty women with fibromyalgia will be equally randomly assigned to the experimental (EX) group and the control group (CON). The participants' age will be between 30 and 40 years and they will have mild restrictive lung affection. The Ex group will attend 3 sessions/week of aerobic training at moderate intensity combined with diaphragmatic breathing exercises for 12 weeks, the CON will only attend 3 sessions/week of diaphragmatic breathing exercises for 12 weeks. The lung functions will be assessed by the spirometry testing. The chest expansion will be determined using a tape measurement. Additionally, exercise capacity will be tested using cardiopulmonary exercise testing protocol. All the outcomes will be examined at baseline, and after 12 weeks of the intervention.
Investigators
Saher Lotfy El Gayar
Assistant Professor of Physiotherapy
Kasr El Aini Hospital
Eligibility Criteria
Inclusion Criteria
- •Well controlled fibromyalgia.
- •Mild restrictive lung affection.
- •Body mass index less than 30kg/m
- •Moderate level of physical activity.
Exclusion Criteria
- •Any chest diseases.
- •Musculoskeletal/ neurological limitations to exercise.
- •Pregnant.
Outcomes
Primary Outcomes
Lung function
Time Frame: At baseline and 12 weeks
Ventilatory function parameters, including forced vital capacity and forced expiratory volume in the first second will be measured by experienced technicians at baseline and after 12 weeks in all groups using the Medgraphics pulmonary function testing system (Breezesuite Ultima PFX, Milano, Italy) in strict adherence to the guidelines outlined in the user manual.
Secondary Outcomes
- Chest expansion(At baseline and 12 weeks)
- Exercise capacity(At baseline and 12 weeks)